- $651.64m
- $623.54m
- $320.20m
- 79
- 49
- 77
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 210 | 247 | 298 | 294 | 320 |
Cost of Revenue | |||||
Gross Profit | 32.5 | 97.6 | 115 | 118 | 112 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 229 | 196 | 230 | 234 | 268 |
Operating Profit | -19.7 | 51 | 68.3 | 59.7 | 52.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.2 | 53 | 136 | 67.8 | 84.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.5 | 54.4 | 175 | 52.2 | 84.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.5 | 54.4 | 175 | 52.2 | 84.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -24.3 | 5.8 | 135 | 50.7 | 84.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.72 | 0.637 | 9.75 | 3.41 | 5.68 |